- ►nih.gov C Cursiefen, C Hofmann-Rummelt, M Küchle, … - British Journal of Ophthalmology, 2003 - bjo.bmj.com Background/aim: During angiogenesis—that is, the outgrowth of new from
pre-existing blood vessels, new capillaries undergo a period of “fine
tuning” when vascular endothelial cells become apoptotic if sufficient ... Cited by 24 - Related articles - BL Direct - All 8 versions
[CITATION] Immunohistochemical localization of VEGF, TGFα and TGFβ 1 in human corneas with …
C Cursiefen, M Küchle, GOH Naumann - Cornea, 1998 - journals.lww.com Results: Of 1,278 human corneal buttons obtained by keratoplasty, 254 (19.9%)
showed angiogenesis. Associated histopathologic diagnoses were (a) scarring
after keratitis (109, 45.4%); (b) graft rejection and insufficiency (73, ... Cited by 35 - Related articles - BL Direct - All 3 versions
C Cursiefen, B Seitz, MR Dana, JW Streilein - Der Ophthalmologe, 2003 - Springer D ie normale Hornhaut ist frei von Blut- und Lymphgefäßen. Im Rahmen
verschiedener Hornhauterkrankungen [6] und postoperativ [12] kann es aber zu
einer Einsprossung neuer Blutgefäße [(Häm)Angiogenese] und Lymphgefäße ... Cited by 6 - Related articles - All 2 versions
C Cursiefen, P Martus, NX Nguyen, A … - Cornea, 2002 - journals.lww.com From the Department of Ophthalmology (CC, NXN, AL, BS, MK),
Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany; and the
Department of Medical Informatics, Biometry, and Epidemiology (PM), Free ... Cited by 14 - Related articles - BL Direct - All 5 versions
[CITATION] Peripheral corneal neovascularization after non-high risk-keratoplasty: influence of short- …
C Cursiefen, H Wenkel, P Martus, A … - Graefes Arch Clin Exp Ophthalmol, 2001 Cited by 8 - Related articles
[CITATION] Roles of thrombospondin 1 and 2 in regulating spontaneous and induced angiogenesis in …
C Cursiefen, S Masli, TF Ng, MR Dana, P … - Invest Ophthalmol Vis Sci, 2004 Cited by 6 - Related articles
F Bock, Y König, F Kruse, M Baier, C … - Graefe's Archive for Clinical and Experimental …, 2008 - Springer Abstract Background To analyze the ability of bevacizumab (Avastin) eye drops to
inhibit corneal neovascularization. Design: interventional case series involving
five patients (age: 42±14 years). Methods Patients with aggressive corneal ... Cited by 25 - Related articles - BL Direct - All 2 versions
F Bock, Y König, T Dietrich, P Zimmermann, M … - Der Ophthalmologe: Zeitschrift der Deutschen …, 2007 - ncbi.nlm.nih.gov BACKGROUND: Recent years have seen tremendous progress in our understanding of
the mechanisms of neovascular diseases of the eye. Antiangiogenic treatment
options are now widely used in the management of age-related maculopathy ... Cited by 17 - Related articles
